Option chain shows key data for Tevogen Bio Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Tevogen Bio Holdings.

Tevogen Bio Holdings (NASDAQ:TVGN) Stock, Option Chain

Tevogen Bio Holdings

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

benzingaai2023_stock_market_trading_setup_close_up_of_multipl_9ea2f44f-9171-417b-a64e-58bbbd995de1_0

News

Contracts

Movers

MSFT

TVGN

Tevogen Bio Holdings Inc (NASDAQ:TVGN) shares are trading higher Monday after the company announced an expanded AI collaboration with Microsoft Corp (NASDAQ:MSFT).

What&#39;s Going On With Tevogen Bio Stock Today?

Closeup,Of,Wall,St.,Street,Sign,And,Large,New,York

Equities

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

Trading Ideas

AAPL

AMZN

GOOG

GOOGL

LGTY

NVDA

SANM

TSLA

TWLO

U.S. stock futures dropped sharply on Monday after China released DeepSeek, an AI model that demonstrates high performance at a lower cost.

US Stock Futures Tumble As DeepSeek Buzz Jolts Big Tech: Expert Says The Chinese AI Model Is Yet To Prove Its Viability At Lower Cost In Long Term

Recent Gains

ACON

ALUR

ASST

AVBP

CNOB

DWTX

HSTM

IPHA

MDXG

The Marygold Companies, Inc. Common Stock

MGLD

MULN

ONCO

PXLW

RMBI

VINC

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket

Tevogen Bio Holdings Inc

Financing

Press Releases

Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding

Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology's Potential as a Scalable Medical Countermeasure

General

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

Health Care

Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans

Management

Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation's Health and Prosperity

Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency

Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision

Tevogen Bio's First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned

Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy

Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations

TVGNW

Abeona Therapeutics

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share

Amarin Corp

Anika Therapeutics

C4 Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharma

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Inhibrx Biosciences

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

ITeos Therapeutics

Kodiak Sciences

Korro Bio

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Lyell Immunopharma

Monopar Therapeutics

Neurogene

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

AVITA Medical

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Tango Therapeutics

Verastem

Voyager Therapeutics, Inc. - Common Stock

Voyager Therapeutics

Y-mAbs Therapeutics

Comments

Tevogen Bio Holdings

Tevogen Bio Holdings (TVGN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga